Table 2.
Effect of Capsifen on administration on relative organ weight of Wistar rats.
| Groups | Liver (%) | Kidney (%) | Heart (%) | Spleen (%) |
|---|---|---|---|---|
| Male group | ||||
| Control | 2.60 ± 0.22 | 0.57 ± 0.08 | 0.29 ± 0.03 | 0.36 ± 0.05 |
| Control R | 1.99 ± 0.26 | 0.41 ± 0.04a | 0.24 ± 0.01 | 0.27 ± 0.06a |
| LD (250 mg) | 2.80 ± 0.41 | 0.57 ± 0.09 | 0.27 ± 0.04 | 0.36 ± 0.06 |
| MD (500 mg) | 1.54 ± 1.06a | 0.57 ± 0.09 | 0.28 ± 0.08 | 0.29 ± 0.07b |
| HD (1000 mg) | 3.39 ± 0.94b | 0.81 ± 0.20b | 0.40 ± 0.07a | 0.39 ± 0.07 |
| HD-R (1000 mg) | 1.94 ± 0.23 | 0.37 ± 0.03 | 0.23 ± 0.03 | 0.23 ± 0.03c |
| Female group | ||||
| Control | 2.64 ± 0.23 | 0.57 ± 0.07 | 0.29 ± 0.03 | 0.36 ± 0.07 |
| Control R | 2.00 ± 0.33a | 0.44 ± 0.09a | 0.25 ± 0.04 | 0.27 ± 0.04a |
| LD (250 mg) | 2.76 ± 0.31 | 0.60 ± 0.05 | 0.30 ± 0.04 | 0.35 ± 0.07 |
| MD (500 mg) | 3.05 ± 0.51 | 0.61 ± 0.16 | 0.30 ± 0.06 | 0.29 ± 0.05 |
| HD (1000 mg) | 3.41 ± 0.38b | 0.86 ± 0.10b | 0.40 ± 0.03a | 0.35 ± 0.06 |
| HD-R (1000 mg) | 2.02 ± 0.35c | 0.42 ± 0.07c | 0.26 ± 0.03 | 0.25 ± 0.03b |
Values are mean ± standard deviation, expressed as the percentage of organ weight/100 g of body weight. 5 animals/sex/group, unless otherwise specified. The values having a superscript significantly differ at p < 0.05 with respective controls.